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Iodinated contrast media used in angiography and computed tomography (CT) scans is an 
important cause of AKI in hospitalized patients undergoing surgery. Contrast induced 
nephropathy leads to AKI soon after contrast media administration. The aim of the study was 
to determine whether the timing of contrast media exposure related to diagnostic imaging 
during the immediate peri-operative period influences the risk of post-operative AKI. 
Methods 
All patients aged 18 or over who underwent diagnostic imaging within 7 days of non-cardiac 
surgery between the1st of January 2003 and 31st of December 2013 in the Tayside region of 
Scotland, UK were included in the analysis. The primary outcome of AKI was defined using 
the KDIGO creatinine based criteria. Multiple logistic regression was performed to identify 
predictors for AKI. 
Results 
Of 9,300 patients, 6,224 were exposed to CM in the immediate peri-operative period and 
3,076 were not. Post-operative AKI occurred in 678 (10.9%) of the 6,224  patients who were 
exposed to CM. On multiple logistic regression, independent predictors of post-operative AKI 
were increasing age, male gender, lower baseline renal function and treatment with ACE 
inhibitors or ARB. Timing of CM exposure did not affect risk of developing AKI, OR  0.972 
(95% CI 0.935 - 1.010), p=0.146. 
Conclusions 
For patients who have either just had or are soon to undergo general surgical procedures 
there appears to be no need to limit CT scan quality by avoiding the administration of 
contrast media. These patients may benefit from the increased diagnostic utility of contrast-




Acute Kidney Injury (AKI) affects 1 in 5 people hospitalized patients with a significant 
proportion of cases estimated to be preventable[1]. It is associated with increased mortality 
of up to 50% in severe AKI, but even mild, transient AKI is associated with both increased 
long term mortality and the future development of chronic kidney disease (CKD)[2, 3].  
For many years it has been widely accepted that one of the leading causes of AKI in 
hospitalized patients is iodinated contrast media (CM) used in angiography and computed 
tomography (CT) scans [4], with contrast induced nephropathy (CIN) leading to AKI soon 
after CM administration. The risk of CIN is negligible in patients with normal renal function 
but the incidence appears to rise to as high as 25% in patients with pre-existing renal 
impairment or in the presence of risk factors such as CKD and diabetes, advanced age and 
use of certain concurrent  medication. CIN is reported to be the third commonest cause of 
new AKI in hospitalized patients, after decreased renal perfusion and medication responsible 
for 11% of cases [5].  
Another important cause of AKI in hospitalized patients is surgery.  The incidence of AKI 
after surgery ranges from 18% to 47% and mortality from 1% to 30% depending on which 
AKI definitions are applied.  Historically it was difficult to reliably establish the incidence of 
AKI due to the lack of a universally accepted definition. Using the now widely accepted 
Kidney Disease Improving Global Outcomes (KDIGO) criteria we have shown that rates of 
AKI rates ranged from 6% in orthopaedic surgery to 25% in vascular surgery[6] highlighting 
the extent of the current problem. 
An apparently synergistic relationship between the “double hits” of surgery and CM exposure 
has been reported in cardiac surgery where operations often take place soon after 
angiography. The incidence of postoperative AKI is correspondingly high at 10-25% 
depending on presence of pre-existing renal impairment. A meta-analysis of studies has 
advocated that as long a gap as clinically feasible be allowed between the nephrotoxic 
insults of surgery and CM exposure [7]. This evidence presents a strong theoretical risk that 
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CM exposure and surgery are separate and complementary risk factors for AKI, and that 
modifying clinical practice by reducing CM exposure in the perioperative period may be a 
potentially effective target to reduce a potentially avoidable risk of AKI in the wider general 
surgical population. 
The aim of our study was to determine whether the timing of contrast media exposure 
related to diagnostic imaging during the immediate peri-operative period influences the risk 
of post-operative AKI in the general surgical population. 
Materials and Methods 
Study Population 
Adults aged 18 or above who underwent non-cardiac surgery and a diagnostic imaging 
investigation including the administration of CM within 7 days of the surgical procedure in a 
hospital in the Tayside region of Scotland from 1st January 2003 to 31st December 2013 
were included in the study. Patients who were receiving chronic renal replacement therapy 
or had missing pre or post-operative creatinines were excluded.  
Ethical Statement 
Anonymised record linkage was conducted according to Health Informatics Centre , 
University of Dundee[8] Standard Operating Procedure. The Tayside Research Ethics 
Committee does not require submission of individual studies that follow this standard 
operating procedure which is Caldicott Guardian approved. The study manuscript has been 
prepared in adherence to the recommendations of the strengthening of the reporting of 
observational studies in epidemiology (STROBE) workshop[9]. 
Data Sources 
Data were linked using the Health Informatics Centre (HIC) at the University of 
Dundee[8]HIC enables anonymized health record linkage for the population of Tayside 
(n=400,000) using a unique identifying Community Health Index (CHI) number. Data were 
linked between the following datasets: Scottish Morbidity Record of hospital admissions 
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(SMR01); laboratory results, medicines dispensed by community pharmacies, Scottish Index 
of Multiple Deprivation (SIMD), the Scottish Care Initiative-Diabetes Collaboration, the 
Scottish Renal Registry and the Healthcare Software Solutions Computerised Radiology 
Information System (HSS CRIS). SMR01 provides information on age, sex, postcode and 
admission and discharge dates and operation procedure codes. Creatinine measurements 
were obtained from the laboratory system. Deprivation category was obtained from Scottish 
Index of Multiple Deprivation and the Scottish Care Initiative-Diabetes Collaboration provided 
information on diabetes type and date of diagnosis. Patients receiving chronic dialysis or 
post renal transplant were identified using the Scottish Renal Registry. Diagnostic imaging 
investigations involving the administration of CM were identified from the HSS CRIS 
radiology system by their specific examination codes with data extracted on type and volume 
of CM administered. 
Outcome 
The outcome of interest was the development of any severity of AKI (Stages 1-3) during the 
first week post-operatively. AKI severity was defined using Kidney Disease Improving Global 
Outcomes Criteria[10]. These criteria were applied using serum creatinine at baseline (most 
recent prior to surgery within 6 months) as pre-operative measurement and maximal serum 
creatinine during the first seven after surgery days as post-operative measurement. Post-
operative AKI was defined using the KDIGO criteria. Patients must have had at least stage 1 
AKI, defined as a rise in serum creatinine of  26.5 μmol/l or more or a post-operative serum 
creatinine of greater than 150% of baseline serum creatinine, to be classified as having post-
operative AKI[10]. 
Statistical Methods 
Baseline characteristics were displayed as mean and standard deviation (SD) for continuous 
variables. Categorical variables were displayed as number and percentage. SIMD 
deprivation and days of CM exposure before surgery were displayed as number and 
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percentage for each category but were included into further analyses as continuous 
variables. 
The cohort comprised of all patients who had undergone surgical procedures and 
radiological investigations involving the administration of CM in the Tayside region of 
Scotland. The index date of entry was the date of admission prior to the surgical procedure 
and the follow-up period was for 7 days. The primary outcome was AKI and was analysed 
using logistic regression with AKI as a binary outcome in the 7 days after surgery. Variables 
entered into the multiple logistic regression analysis were: age, gender, SIMD deprivation, 
baseline renal function, diabetes, prescription of ACE inhibitors or ARBs, prescription of 
HMG Co reductase inhibitors (statins), prescription of NSAIDs, prescription of loop diuretics 
and days of CM exposure before surgery. Baseline renal function was assessed using 
estimated glomerular filtration rate (eGFR), which was calculated using the CKD-EPI 
equation[11]. The rates were then categorised as less than 29, 30-44, 45-59 and greater 
than 60. Missing values of SIMD were imputed using multiple imputation[12]. Results are 
expressed as Odds Ratios (OR) and their 95% confidence intervals.  In addition, ordinal 
logistic regression was carried out with the outcome as the three stages of AKI in order to 
assess whether any of the variables were associated with severity of AKI.  Analyses were 
implemented in Statistical Analysis Software (SAS v9.3). 
Results 
Between the 1st Jan 2003 and 31st Dec 2013, 13,482 patients in the Tayside region of 
Scotland underwent surgery and also had diagnostic imaging investigations performed. 
Among the 13,482 patients, only 9,300 had SCr tested within 6 months before and 7 days 
after surgery. Of the 9,300 patients, 6,224 were exposed to CM in the immediate peri-
operative period and 3,076 were not. Post-operative AKI occurred in 678 (10.9%) of the 
6,224  patients who were exposed to CM. Of these 540 were Stage 1, 91 stage 2 and 47 




Baseline characteristics of patients exposed to and not exposed to CM with and without AKI 
are shown in Table 1. Mean age was higer in those with AKI (71.2 SD 13.9) compared to 
those without  AKI (64.8 SD 16.8). Baseline renal function was lower in those with AKI 
(median eGFR: 60 ml/min (IQR 40 - 83) compared to those without AKI (median eFGR: 80 
ml/min (IQR: 59 - 97). Post-operative AKI occurred in 678 (10.9%) of the 6,300 patients who 
were exposed to CM and 329 (10.7%) of 3076 not exposed to contrast. Relative risk of 
developing AKI in the patients exposed to contrast media was 1.018 (95% CI 0.899 - 1.153). 
Predictive Variables for AKI 
Results from multiple logistic regression are shown in Table 2. After entering 10 variables 
into the multiple logistic regression model, independent predictors of post-operative AKI 
were increasing age, male gender, lower baseline renal function and treatment with 
Angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARB). 
Timing of CM exposure did not affect risk of developing AKI, OR  0.972 (95% CI 0.935 - 
1.010), p=0.146. 
 
Ordinal logistic regression for stages of post-operative AKI 
Results of ordinal logistic regression with stage of AKI as the outcome are shown in Table 3.  
Only baseline renal function was significantly associated with the severity of post-operative 
AKI. The time in days btween use of CM and surgery  exposure after adjustment for baseline 
renal function did not significantly impact the severity of post-operative AKI OR 0.907 (95% 







We have demonstrated that exposure to CM appears to confer little or no additional risk of 
AKI in patients undergoing general surgical procedures. In contrast, several other well 
known risk factors for AKI such as male gender, baseline renal function, presence of 
diabetes and treatment with ACE inhibitors and ARBs remained strong predictors of AKI in 
this clinical setting . 
Iodinated radiological CM are known to be nephrotoxic so it is perhaps surprising that this 
nephrotoxic effect does not appear to add appreciably to the risk of developing AKI in 
patients undergoing general surgical procedures.  It seems unlikely that the nephrotoxic 
effect of CM are mitigated by the physiolological insults of surgery and the underlying 
medical conditions precipitating the need for surgery.  It may be that the the physiological 
derangements related to the surgery and underlying patient co-morbidities play a greater 
role than the effect of  exposure to CM. For this to be the case the additional nephrotoxic 
effect of CM exposure in this clinical setting must be small and, for all practical purposes, 
negligible for these patients. 
A recent large study of almost 8 million hospitalised patients in 2009 in the United States 
showed that CM exposure  was not associated with an increased risk of AKI. The authors 
concluded that the risk of CIN may be overstated in the literature and overestimated by 
clinicians [13].  An accompanying editorial suggested “it may be appropriate to moderately 
liberalize the overall use of contrast” whilst continuing to carefully weigh the potential 
benefits versus the risks of the procedure[14]. This study was however limited by the fact 
that AKI was defined using ICD-9 codes perhaps underestimating its incidence. Another 
large study reported that CM exposure in the absence of pre-existing CKD was not 
associated with increased risk of AKI[15] . A smaller study of 100 hospitalised patients with 
stable renal function found similarly that AKI following CM exposure was rare in the absence 
of confounding risk factors such as nephrotoxic medications and CKD[16] . Our findings that 
CM exposure did not add appreciably to the risk of AKI in patients undergoing surgery lends 
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support to the suggestion that the influence of CM exposure alone on the risk of AKI may be 
clinically insignificant where other risk factors are present. 
The current study draws data from a twelve year time period during which both awareness of 
CIN and preventive measures have evolved.  Although impossible to define numerically, 
during the study period, there has undoubtedly been increasing clinician awareness of CIN 
leading to the development of several collaborative “renal protection” protocols which 
appeared to be better adhered to than dictats emanating unilaterally from the department of 
radiology. Changes in information technology have also facilitated a more considered 
approach to patients with impaired renal function. These include  improvements in the 
hospital information systems (HIS) allowing easier access to uptodate blood results and  
integration of HIS with the radiology information system (RIS). This allows the radiology 
department staff to view the most recent eGFR results for patients at the time of appointing 
radiological procedures. This facilitates discussion and management of patients with 
impaired renal function undergoing contrast enhhanced scans.  Advance consideration of 
challenging cases would sometimes result in deferred radiological examinations, careful fluid 
management around the time of CM administration, or even alteration of investigation plans 
to utilise tests which avoid CM altogether. 
A “renal protection” guideline  was implemented in 2012 in Tayside. This  recommended 
administering either 0.9% saline for 12 hours pre and post scan or 1.26% sodium 
bicarbonate for 1 hour pre and 6 hours post scan in high risk patients. Prior to 2012, there 
was no hospital wide guideline in place and so practice varied considerably.  Contrast 
agents used during the study period included iopamidol, iopromide and iohexol.  Iso-osmolar 
agents reported to be associated with reduced risk of renal impairment were employed in a 
very small number of patients (dozens) in the mid-2000s but this approach did not follow any 




Strengths of our study include the large cohort size and the use of the widely accepted 
KDIGO criteria to define AKI allowing inclusion of milder forms of AKI. However our study is 
limited by the use of routinely collected data preventing the inclusion of intra-operative 
factors, exact dose of contrast administration  and in-patient prescribing which may influence 
risk of AKI. In addition our population was predominantly Caucasian and so our findings may 
not be applicable to other ethnicities. We were unable to use data on co-morbidities due to 
under reporting[18]. We therefore used number of prescribed medications prior to admission 
which has been shown to correlate well with co-morbidity[19]. 
CT scanning has become the workhorse imaging investigation in hospitalized patients with 
abdominal and cardiovascular disease[20, 21]. Although CT of the abdomen can be 
performed without intravenous CM, the use of CM facilitates good accuracy and a high level 
of diagnostic confidence [21]. Although radiology staff are generally aware of CIN and its risk 
factors it has been suggested that more could be done by radiologists and referring 
physicians to reduce the risk of CIN [22]. Anecdotally we are aware that radiologists often 
avoid administering intravenous CM during CT scanning of patients who are considered to 
be at risk of CIN, and again anecodotally we are aware that radiologists consider such CT 
scans to be of substantially poorer diagnostic utility than CT scans performed with 
intravenous CM. 
An episode of AKI, even after biochemical resolution, is associated with long term 
consequences such as greater risk of readmission, development and progression of chronic 
kidney disease (CKD) and poorer long term survival. In addition to these adverse health 
outcomes, AKI has a significant economic impact. Increased costs are due to increased 
length of hospital in-patients stay, increased investigation, intensive care admission and 
renal replacement therapy (RRT). In the United Kingdom the cost of in-hospital AKI alone 




In the field of cardiac surgery a strong relationship has been demonstrated between 
synchronous CM exposure and high CM volumes and an increased risk of postoperative 
AKI[7]. Dose-response type relationships have been demonstrated between the risk of AKI 
and (i) close timing of angiography and surgery [7] and (ii) the amount of CM 
administered[24]. A significant association has been identified between AKI and volume of 
CM exposure at endovascular aneurysm repair (EVAR), with a corresponding deleterious 
effect on in-hospital mortality[25]. 
This data is lacking in the field of non-cardiac surgery where the usual source of CM 
exposure is CT scanning. CM-enhanced CT scans are commonly performed on patients 
undergoing non-cardiac surgery in both the preoperative and postoperative periods. CM-
enhanced CT scans and angiography are commonly performed in the immediate pre- and 
post-operative periods, especially in the more vulnerable group of patients undergoing 
emergency surgery.  
Shorter intervals between contrast media exposure and surgery were not associated with an 
increase in the risk of post-operative AKI. However male gender, baseline renal function, 
presence of diabetes and treatment with ACE inhibitors and Angiotensin Receptor Blockers 
were significant predictors of post-operative AKI. For patients who have either just had or are 
soon to undergo general surgical procedures there appears to be no need to limit CT scan 
quality by avoiding the administration of contrast media. These patients may benefit from the 
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Table 1: Baseline characteristics of patients undergoing surgery and radiological investgations exposed and not exposed to CM with and 
without AKI 
Characteristics 
Exposure to contrast media (n = 6224) Non-exposure to CM (n = 3076) 
AKI 
(n=678) 
No AKI Overall AKI 
(n=329) 
No AKI Overall 
Mean (SD) age (years) 70.8 (14.5) 64.0 (17.0) 64.8 (16.9) 71.9 (12.4) 66.3 (16.2) 66.9 (15.9) 
Gender (M:F) 376 (55.5%) 2774 (50.0%) 3150 (50.6%) 181 (55.0%) 1374 (50.0%) 1555 (50.6%) 
SIMD deprivation 
category: 
      
    1 (most deprived) 126 (18.6%) 1166 (21.0%) 1292 (20.8%) 85 (25.8%) 587 (21.4%) 672 (21.8%) 
    2 112 (16.5%) 988 (17.8%) 1100 (17.7%) 52 (15.8%) 497 (18.1%) 549 (17.8%) 
    3 105 (15.5%) 951 (17.1%) 1056 (17.0%) 51 (15.5%) 466 (17.0%) 517 (16.8%) 
    4 208 (30.7%) 1479 (26.7%) 1687 (27.1%) 103 (31.3%) 733 (26.7%) 836 (27.2%) 
    5 (lease deprived) 121 (17.8%) 865 (15.6%) 986 (15.8%) 33 (10.0%) 419 (15.3%) 452 (14.7%) 
    Missing 6 (0.9%) 97 (1.7%) 103 (1.7%) 5 (1.5%) 45 (1.6%) 50 (1.6%) 
eGFR category (mL/min):       
    <29 97 (14.3%) 225 (4.1%) 322 (5.2%) 38 (11.6%) 124 (4.5%) 162 (5.3%) 
    30-44 117 (17.3%) 375 (6.8%) 492 (7.9%) 53 (16.1%) 258 (9.4%) 311 (10.1%) 
    45-59 126 (18.6%) 672 (12.1%) 798 (12.8%) 64 (19.5%) 407 (14.8%) 471 (15.3%) 
    >60 338 (49.9%) 4274 (77.1%) 4612 (74.1%) 174 (52.9%) 1958 (71.3%) 2132 (69.3%) 
Diabetes 144 (21.2%) 807 (14.6%) 951 (15.3%) 68 (20.7%) 399 (14.5%) 467 (15.2%) 
No. receiving ACE 
inhibitors or ARBs 
288 (42.5%) 1508 (27.2%) 1796 (28.9%) 154 (46.8%) 754 (27.4%) 908 (29.5%) 
No. receiving NSAIDs  142 (20.9%) 1187 (21.4%) 1329 (21.4%) 62 (18.8%) 494 (18.0%) 556 (18.1%) 
No. receiving statins 289 (42.6%) 1644 (29.6%) 1933 (31.1%) 137 (41.6%) 815 (29.7%) 952 (30.9%) 
No. receiving loop 
diuretics 
157 (23.2%) 813 (14.7%) 970 (15.6%) 89 (27.0%) 465 (16.9%) 554 (18.0%) 
No. of prescribed drugs:       
    None 19 (2.8%) 290 (5.2%) 309 (5.0%) 14 (4.3%) 180 (6.6%) 194 (6.3%) 
    1-5 110 (16.2%) 1482 (26.7%) 1592 (25.6%) 65 (19.8%) 734 (26.7%) 799 (26.0%) 
    6-10 222 (32.7%) 1590 (28.7%) 1812 (29.1%) 113 (34.3%) 853 (31.1%) 966 (31.4%) 
    11-15 162 (23.9%) 1123 (20.2%) 1285 (20.6%) 66 (20.1%) 517 (18.8%) 583 (19.0%) 
    16-20 94 (13.9%) 578 (10.4%) 672 (10.8%) 40 (12.2%) 294 (10.7%) 334 (10.9%) 
    >20 71 (10.5%) 483 (8.7%) 554 (8.9%) 31 (9.4%) 169 (6.2%) 200 (6.5%) 
Timing of CM (days)       
    0 (same day) 310 (45.7%) 2299 (41.5%) 2609 (41.9%) -- -- -- 
    1 118 (17.4%) 1075 (19.4%) 1193 (19.2%) -- -- -- 
    2 78 (11.5%) 546 (9.8%) 624 (10.0%) -- -- -- 
    3 37 (5.5%) 402 (7.2%) 439 (7.1%) -- -- -- 
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    4 34 (5.0%) 312 (5.6%) 346 (5.6%) -- -- -- 
    5 37 (5.5%) 302 (5.4%) 339 (5.4%) -- -- -- 
    6 36 (5.3%) 301 (5.4%) 337 (5.4%) -- -- -- 
















Table 2: Predictive variables for AKI on multivariable logistic regression analysis in patients undergoing surgery and radiological investigations 
with CM administration(n=6224) 
 Odds ratio (95% CI) P value 
Age at operation (years) 1.010 (1.004 – 1.017) 0.002 
Male gender 1.336 (1.130 – 1.580) 0.001 
SIMD deprivation 1.060 (0.998 – 1.127) 0.060 
eGFR category (mL/min):   
    <29 (reference) --  
    30-44 0.696 (0.505 – 0.960) 0.027 
    45-59 0.434 (0.319 – 0.592) < 0.001 
    >60 0.230 (0.174 – 0.304) < 0.001 
Diabetes 1.103 (0.883 – 1.378) 0.387 
ACE inhibitors or ARBs 1.252 (1.031 – 1.520) 0.023 
NSAIDs  1.013 (0.824 – 1.246) 0.902 
Statins 1.179 (0.968 – 1.435) 0.102 
Loop diuretics 1.006 (0.804 – 1.259) 0.955 
No. of prescribed drugs:   
    None (reference) --  
    1-5 0.947 (0.567 – 1.581) 0.834 
    6-10 1.352 (0.813 – 2.248) 0.246 
    11-15 1.175 (0.693 – 1.993) 0.550 
    16-20 1.286 (0.737 – 2.244) 0.376 
    >20 1.123 (0.631 – 2.001) 0.693 






Table 3. Ordinal logistic regression analysis by stage in  patients with post-operative AKI undergoing surgery and radiological investigations 
with CM administration  (n = 678). 
 Odds ratio (95% CI) P value 
Age at operation (years) 0.996 (0.982 – 1.010) 0.573 
Male gender 1.137 (0.764 – 1.690) 0.526 
SIMD deprivation 1.010 (0.879 – 1.161) 0.887 
eGFR category (mL/min):   
    <29 (reference) --  
    30-44 1.723 (0.746 – 3.984) 0.203 
    45-59 2.322 (1.040 – 5.186) 0.040 
    >60 3.270 (1.599 – 6.688) 0.001 
Diabetes 1.294 (0.787 – 2.127) 0.310 
ACE inhibitors or ARBs 1.252 (0.801 – 1.956) 0.323 
NSAIDs  1.277 (0.796 – 2.048) 0.310 
Statins 1.194 (0.769 – 1.854) 0.430 
Loop diuretics 0.803 (0.480 – 1.342) 0.402 
No. of prescribed drugs:   
    None (reference) --  
    1-5 0.862 (0.279 – 2.669) 0.797 
    6-10 0.790 (0.257 – 2.434) 0.682 
    11-15 0.754 (0.232 – 2.449) 0.638 
    16-20 0.787 (0.226 – 2.738) 0.706 
    >20 0.653 (0.175 – 2.435) 0.525 
Timing of CM exposure (days) 0.907 (0.823 – 1.000) 0.051 
 
 
